Somnum Pharma, Inc. — Form D
Somnum Pharma, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-29. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-11-29
- Form: D
- Accession: 0001178913-24-003875
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $800K
- Date of first sale: 2024-11-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-530745
Issuer
- Name: Somnum Pharma, Inc.
- CIK: 0002046710
- Entity type: Corporation
- Jurisdiction: NEW YORK
- Incorporated: 2024
- Address: 4 EAST 70TH STREET, 9A, NEW YORK, NY, 10021
- Phone: 347-495-4416
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Orrin Devinsky | Director | New York, NY |
| Michael Jasulavic | Director | New York, NY |
More